Compare
HeartBeam, Inc. vs QTREX Quantum Ltd. vs Medinotec Inc. vs Bluejay Diagnostics, Inc.
| Latest fiscal year | HeartBeam, Inc. BEAT | QTREX Quantum Ltd. QTEX | Medinotec Inc. MDNC | Bluejay Diagnostics, Inc. BJDX |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-02-28 | 2025-12-31 |
| Revenue | n/a | $289.0K | $9.73M | n/a |
| Revenue growth (YoY) | n/a | n/a | +6.8% | n/a |
| Gross margin | n/a | 0.7% | 52.7% | n/a |
| Operating margin | n/a | n/m | 11.2% | n/a |
| Net margin | n/a | n/m | 8.2% | n/a |
| Net income | -$21.02M | -$13.22M | $794.5K | -$6.85M |
| EPS (Diluted) | -$0.62 | -$0.45 | n/a | -$15.25 |
| Operating cash flow | -$13.99M | -$9.86M | $906.8K | -$6.05M |
| Free cash flow | -$14.59M | -$9.96M | $905.4K | -$6.23M |
| Cash & equivalents | $4.38M | $3.16M | n/a | $5.16M |
| Total assets | $5.84M | $5.34M | $6.81M | $7.12M |
| Total liabilities | $3.24M | n/a | $1.10M | $1.14M |
| Shareholders' equity | $2.60M | $2.32M | $5.71M | $5.98M |
| Return on year-end equity | -807.3% | -569.1% | 13.9% | -114.6% |
| Shares outstanding | 26.96M | 35.95M | 11.76M | 604.5K |
Revenue, most recent five fiscal years
| Fiscal year | HeartBeam, Inc. | QTREX Quantum Ltd. | Medinotec Inc. | Bluejay Diagnostics, Inc. |
|---|---|---|---|---|
| Latest | n/a | $289.0K Ended 2025-12-31 | $9.73M Ended 2026-02-28 | $249.0K Ended 2022-12-31 |
| 1 year earlier | n/a | $0 Ended 2024-12-31 | $9.11M Ended 2025-02-28 | n/a |
| 2 years earlier | n/a | $0 Ended 2023-12-31 | $5.02M Ended 2024-02-29 | n/a |
| 3 years earlier | n/a | n/a | $999.6K Ended 2023-02-28 | n/a |
| 4 years earlier | n/a | n/a | n/a | n/a |